Based on these observations, we conclude that STC2 suppresses EMT to hinder cell migration and invasion via the PKC/Claudin-1-mediated signaling, which may be useful for breast cancer diagnosis and treatment. The gene discussed is CLDN1; the disease is breast carcinoma.